Lixte Biotechnology Holdings, Inc. (LIXT) insider trading.
In Q3 2026, insiders at Lixte Biotechnology Holdings, Inc. reported 6 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 6
- Last filed
- 2026-07-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Felix Lourdes | Director | 1 | 0 | 0 |
| Holloway Michael Andrew | Director | 1 | 0 | 0 |
| Primus Guy Warren | Director | 1 | 0 | 0 |
| Pursglove Geordan Garrett | Director, Officer · CEO and Chairman of the Board | 1 | 0 | 0 |
| Sawyer Jason David | Director | 1 | 0 | 0 |
| Stazzone Peter | Officer · Chief Financial Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Felix Lourdes | A (A) | 30,000 | $0 | 55,000 | Form 4 |
| 2026-07-01 | Holloway Michael Andrew | A (A) | 15,000 | $0 | 40,000 | Form 4 |
| 2026-07-01 | Primus Guy Warren | A (A) | 15,000 | $0 | 40,000 | Form 4 |
| 2026-07-01 | Pursglove Geordan Garrett | A (A) | 350,000 | $0 | 700,000 | Form 4 |
| 2026-07-01 | Sawyer Jason David | A (A) | 40,000 | $0 | 65,000 | Form 4 |
| 2026-07-01 | Stazzone Peter | A (A) | 50,000 | $0 | 100,000 | Form 4 |
Transaction codes in this quarter
Get LIXT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1335105&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · Lixte Biotechnology Holdings, Inc. on SEC.gov
Questions
Are insiders buying or selling Lixte Biotechnology Holdings, Inc. (LIXT)?
In Q3 2026, insiders at Lixte Biotechnology Holdings, Inc. reported 6 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Lixte Biotechnology Holdings, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/lixt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.